Literature DB >> 11916498

Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.

Naji Aldosari1, Rodney N Wiltshire, Amalia Dutra, Evelin Schrock, Roger E McLendon, Henry S Friedman, Darell D Bigner, Sandra H Bigner.   

Abstract

Cell lines and xenografts derived from medulloblastomas are useful tools to investigate the chromosomal changes in these tumors. Here we used G-banding, fluorescence in situ hybridization (FISH), spectral karyotyping (SKY), and comparative genomic hybridization to study 4 medulloblastoma cell lines and 1 xenograft. Cell line D-425 Med had a relatively simple karyotype, with a terminal deletion of 10q and amplification of MYC in double-minutes (dmins). FISH demonstrated that an apparent isochromosome (17q) by routine karyotyping was actually an unbalanced translocation between 2 copies of chromosome 17. Cell line D-556 Med also had a simple near-diploid stemline with an unbalanced 1;13 translocation resulting in a gain of 1q, an isochromosome (17q), and dmins. These findings were initially described using routine G-banded preparations, and FISH showed that the dmins were an amplification of MYC and the i(17q) was an isodicentric 17q chromosome. The other finding was confirmed by FISH, SKY, and comparative genomic hybridization. Cell lines D-721 Med and D-581 Med had complex karyotypic patterns that could be completely characterized only when FISH and SKY were used. Xenograft D-690 Med also had a complex pattern that FISH and SKY were helpful in completely elucidating. Interestingly, balanced reciprocal translocations were seen as well as complicated unbalanced translocations and marker chromosomes. Comparative genomic hybridization demonstrated only a deletion of 10q22-10q24, supporting the idea that despite the complexity of the chromosomal rearrangements, minimal alterations in the overall chromosomal content had occurred. This study demonstrates that routine cytogenetic preparations are adequate to describe chromosomal abnormalities in occasional medulloblastoma samples, but a broader spectrum of molecular cytogenetic methods is required to completely analyze most of these tumor samples.

Entities:  

Mesh:

Year:  2002        PMID: 11916498      PMCID: PMC1920654          DOI: 10.1093/neuonc/4.2.75

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  12 in total

Review 1.  Double minutes, cytogenetic equivalents of gene amplification, in human neoplasia - a review.

Authors:  Erich Gebhart
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

2.  MiR-206, a Cerebellum Enriched miRNA Is Downregulated in All Medulloblastoma Subgroups and Its Overexpression Is Necessary for Growth Inhibition of Medulloblastoma Cells.

Authors:  Pooja Panwalkar; Aliasgar Moiyadi; Atul Goel; Prakash Shetty; Naina Goel; Epari Sridhar; Neelam Shirsat
Journal:  J Mol Neurosci       Date:  2015-04-10       Impact factor: 3.444

3.  Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.

Authors:  Barbara Klink; Ben Schlingelhof; Martin Klink; Karen Stout-Weider; Stephan Patt; Evelin Schrock
Journal:  Cell Oncol (Dordr)       Date:  2011-05-03       Impact factor: 6.730

4.  Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Regia Caroline Lira; Augusto Faria Andrade; Paola Fernanda Fedatto; Gustavo Alencastro Veiga Cruzeiro; Ricardo Bonfim Silva; Aparecida Maria Fontes; Elvis Terci Valera; Michael Bobola; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

5.  Disruption of the ciliary GTPase Arl13b suppresses Sonic hedgehog overactivation and inhibits medulloblastoma formation.

Authors:  Sarah N Bay; Alyssa B Long; Tamara Caspary
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

6.  Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.

Authors:  A O von Bueren; M D Bacolod; C Hagel; K Heinimann; A Fedier; U Kordes; T Pietsch; J Koster; M A Grotzer; H S Friedman; G Marra; M Kool; S Rutkowski
Journal:  Br J Cancer       Date:  2012-09-13       Impact factor: 7.640

7.  MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1.

Authors:  Kedar Yogi; Epari Sridhar; Naina Goel; Rakesh Jalali; Atul Goel; Aliasgar Moiyadi; Rahul Thorat; Pooja Panwalkar; Atul Khire; Archya Dasgupta; Prakash Shetty; Neelam Vishwanath Shirsat
Journal:  Oncoscience       Date:  2015-03-02

8.  BET bromodomain inhibition of MYC-amplified medulloblastoma.

Authors:  Pratiti Bandopadhayay; Guillaume Bergthold; Brian Nguyen; Simone Schubert; Sharareh Gholamin; Yujie Tang; Sara Bolin; Steven E Schumacher; Rhamy Zeid; Sabran Masoud; Furong Yu; Nujsaubnusi Vue; William J Gibson; Brenton R Paolella; Siddhartha S Mitra; Samuel H Cheshier; Jun Qi; Kun-Wei Liu; Robert Wechsler-Reya; William A Weiss; Fredrik J Swartling; Mark W Kieran; James E Bradner; Rameen Beroukhim; Yoon-Jae Cho
Journal:  Clin Cancer Res       Date:  2013-12-02       Impact factor: 12.531

9.  An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells.

Authors:  Zheng-Mei Xiong; Christina LaDana; Di Wu; Kan Cao
Journal:  Aging (Albany NY)       Date:  2013-04       Impact factor: 5.682

10.  Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells.

Authors:  Frank Eckerdt; Elspeth Beauchamp; Jonathan Bell; Asneha Iqbal; Bing Su; Rikiro Fukunaga; Rishi R Lulla; Stewart Goldman; Leonidas C Platanias
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.